| PERIOD ENDING | 27-Sep-09 | 30-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 2,243,000 | 2,625,000 | 2,614,000 | 3,220,000 | | Cost of Revenue | 1,270,000 | 1,561,000 | 1,498,000 | 1,870,000 | | | Gross Profit | 973,000 | 1,064,000 | 1,116,000 | 1,350,000 | | | Operating Expenses | | Research Development | 354,000 | 421,000 | 393,000 | 411,000 | | Selling General and Administrative | 668,000 | 782,000 | 843,000 | 916,000 | | Non Recurring | 51,000 | 79,000 | 49,000 | 222,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (100,000) | (218,000) | (169,000) | (199,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 50,000 | 5,000 | (8,000) | | Earnings Before Interest And Taxes | (113,000) | (168,000) | (169,000) | (202,000) | | Interest Expense |
-
| 2,000 | (1,000) | (10,000) | | Income Before Tax | (113,000) | (170,000) | (168,000) | (192,000) | | Income Tax Expense | 7,000 | (23,000) | 33,000 | 17,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (122,000) | (147,000) | (201,000) | (209,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (120,000) | (147,000) | (201,000) | (209,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($120,000) | ($147,000) | ($201,000) | ($209,000) |
|
0.67% Nasdaq 0.00%
Income Statement
